Physicians across Inception Fertility’s global network, The Prelude Network, to present 40 abstracts highlighting emerging research across fertility, genetics, family building, and reproductive health.

HOUSTON, TX, October 22, 2026 (EZ Newswire) -- Inception Fertility™ (Inception), the largest provider of comprehensive fertility products and services in North America, announced today that 40 abstracts from its clinical network, The Prelude Network® (Prelude), have been accepted by the American Society for Reproductive Medicine (ASRM) to be presented at the 2026 ASRM Scientific Congress, taking place Oct. 24–28, 2026, in Baltimore, Maryland.
ASRM is a professional organization dedicated to advancing the science and practice of reproductive medicine. Its annual Scientific Congress is a gathering of multi-disciplinary professionals who share the latest scientific breakthroughs and discoveries in reproductive endocrinology and infertility.
"Research and innovation are at the heart of advancing fertility care and expanding what's possible for patients and families," said TJ Farnsworth, founder and CEO of Inception Fertility, the parent company of Prelude. "We’re proud to see 40 abstracts from across The Prelude Network recognized for presentation at this year's ASRM Scientific Congress, reflecting the dedication and expertise of our physicians and researchers. Their work continues to deepen our understanding of infertility and explore new approaches to improving treatment and outcomes for patients."
Physicians from across Prelude's global network, including NYU Langone Fertility Center, Reproductive Medicine Group, IVFMD, and Pacific Fertility Center will present findings that explore some of the field's most timely and complex questions, including age-related infertility, the impact of stress on IVF, LGBTQ+ family building, euploid embryos, oncofertility, and genetic testing.
"Meaningful progress in reproductive medicine depends on research that advances our understanding of infertility and translates scientific discovery into better care for patients," said Dr. Jamie Grifo, Program Director at NYU Langone Fertility Center and Chief Executive Physician at Inception Fertility. "The breadth of research being presented by physicians across The Prelude Network reflects our collective commitment to advancing the field and addressing some of the most important challenges facing patients today. I'm proud of our colleagues for their contributions and look forward to the important conversations these studies will generate."
For media attending the 2026 ASRM Scientific Congress who would like to connect on-site with Prelude physicians to further discuss their abstracts, or for media interested in reporting in any one of these studies, please contact Mia Humphreys at MHumphreys@kruppagency.com.
About Inception Fertility
Inception Fertility™ (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science, and medicine in an effort to enhance each patient's experience and achieve better outcomes.
Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT), and fertility preservation services — and they continue to lead the industry by building on these technologies by through development, research, and thought leadership.
Through its growing family of national organizations — which includes The Prelude Network®, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations.
About The Prelude Network
The Prelude Network® (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility™, a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility.
Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists, and practitioners by focusing on an excellence in science, medicine, and the patient experience. The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others.
Those clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Fertility Houston (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida).
Media Contact
mhumphreys@kruppagency.com
+1 239-297-6592